NERM
RVNC

New England Research & Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

New England Research & Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,875
Closed -$225K – 174
2023
Q2 		$225K Buy
+8,875
New +$225K 0.13% 129